Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands deal

NEW YORK — Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion in a deal that would create a massive consumer health goods company.